Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KOSÉ Corporation is a prominent Japanese cosmetics and skincare company that integrates advanced life science research into its product development. The company operates a significant R&D infrastructure dedicated to skin biology, focusing on areas such as hyperpigmentation, skin aging, and barrier function. Through its subsidiary and joint ventures, notably with the dermatology-focused pharmaceutical company Maruho, KOSÉ develops "quasi-drugs" and therapeutic skincare solutions for conditions like xerosis and atopic dermatitis. Their innovative research also extends into regenerative medicine, utilizing induced pluripotent stem (iPS) cells to study skin aging and develop next-generation dermatological treatments. KOSÉ's portfolio includes globally recognized brands such as Decorté, Sekkisei, and Tarte, supported by a commitment to high-quality manufacturing and scientific rigor.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kose.